High-field MR Imaging in Migraine, Visual Snow and Epilepsy

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
MigraineEpilepsyVisual Snow Syndrome
Interventions
DIAGNOSTIC_TEST

Structural MRI

We will examine migraine and epilepsy patients as well as healthy controls using conventional structural MRI in the brain and spinal cord including T1-, T2-, and T2\*-weighted sequences

DIAGNOSTIC_TEST

Quantitative MRI

We will examine migraine and epilepsy patients as well as healthy controls using quantitative MRI in the brain and spinal cord. This includes multi-parameter mapping (MPM) and quantitative susceptibility mapping (QSM).

DIAGNOSTIC_TEST

Diffusion MRI

We will examine migraine and epilepsy patients as well as healthy controls using diffusion MRI in both brain and spinal cord.

DIAGNOSTIC_TEST

fMRI

We will examine migraine and epilepsy patients as well as healthy controls using resting-state and task fMRI (including sensory stimulation using pain stimulus) in both brain and spinal cord.

DIAGNOSTIC_TEST

MR Spectroscopy

We will examine migraine and epilepsy patients as well as healthy controls using MR Spectroscopy in both brain and spinal cord.

Trial Locations (2)

8008

RECRUITING

Klinik Lengg, Zurich

8091

RECRUITING

University Hospital Zurich, Zurich

All Listed Sponsors
collaborator

Balgrist University Hospital

OTHER

lead

University of Zurich

OTHER